Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

GYRE holding history

Gyre Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GYRE overviewAll 13F holders of GYREFull Q2 2026 holdings

Shares (Q2 2026)
532,950
Value
$3.51M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GYRE by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026532,950$3.51M<0.1%+101,536+23.5%AddedHolders
Q1 2026431,414$3.01M<0.1%+8,192+1.9%AddedHolders
Q4 2025423,222$2.99M<0.1%+48,602+13.0%AddedHolders
Q3 2025374,620$2.80M<0.1%−27,089−6.7%ReducedHolders
Q2 2025401,709$2.95M<0.1%+89,390+28.6%AddedHolders
Q1 2025312,319$2.41M<0.1%+8,221+2.7%AddedHolders
Q4 2024304,098$3.68M<0.1%+451+0.1%AddedHolders
Q3 2024303,647$3.81M<0.1%+43,840+16.9%AddedHolders
Q2 2024259,807$3.10M<0.1%+99,218+61.8%AddedHolders
Q1 2024160,589$2.81M<0.1%+26,164+19.5%AddedHolders
Q4 2023134,425$3.45M<0.1%−124,321−48.0%ReducedHolders
Q3 2023258,746$124.8K<0.1%−11,287−4.2%ReducedHolders
Q2 2023270,033$94.9K<0.1%00.0%UnchangedHolders
Q1 2023270,033$55.9K<0.1%−4,554−1.7%ReducedHolders
Q4 2022274,587$144.0K<0.1%−678−0.2%ReducedHolders
Q3 2022275,265$138.0K<0.1%00.0%UnchangedHolders
Q2 2022275,265$489.0K<0.1%−23,936−8.0%ReducedHolders
Q1 2022299,201$197.0K<0.1%+12,616+4.4%AddedHolders
Q4 2021286,585$261.0K<0.1%−64,956−18.5%ReducedHolders
Q3 2021351,541$1.44M<0.1%+19,062+5.7%AddedHolders
Q2 2021332,479$1.44M<0.1%−201,893−37.8%ReducedHolders
Q1 2021534,372$2.69M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.